Pfizer’s Dacomitinib And More Biosimilar Hopefuls Among New EMA Filings

 
• By Neena Brizmohun and Ian Schofield
  
Samples of medicines, tablets, capsules, vitamins, and placebo
Eight new marketing applications are on the EMA's latest list of products for review

More from Product Reviews

More from Pink Sheet